To assist in revising lecture on cardiovascular formulations
|
Created by jenny schneider
almost 10 years ago
|
|
Ratings (0)
| 0 |  |
|
| 0 |  |
|
| 0 |  |
|
| 0 |  |
|
| 0 |  |
0 comments
Close
|
|
Created by jenny schneider
almost 10 years ago
|
|
| 0 | |
|
| 0 | |
|
| 0 | |
|
| 0 | |
|
| 0 | |
Describe the design of a reservoir system transdermal GTN patch
Describe the design of a matrix system transdermal GTN patch
Why do we administer glyceryl trinitrate tablets (Anginine) sublingually?
How should a patient store Anginine (GTN) tablets and why?
Why are patients instructed to apply a GTN transdermal patch at 8am and remove at 8pm?
Explain mechanism of action of glyceryl trinitrate
what is an advantage of GTN as a spray formulation? (nitrolingual spray)
What directions would you give patient on using GTN as a spray
Why do we not give isosorbide mononitrate extended release tablets twice daily (every 12h)
